Implementation Science of Integrating Pre-Exposure Prophylaxis in Pharmacist-Led Services in the United States

Authors:

Abstract
Background Racial inequities in HIV in the United States (US) are pervasive. Pre-exposure prophylaxis (PrEP) is one of the most effective yet underutilized HIV prevention strategies, and stark inequities in PrEP uptake exist. Lack of access to PrEP clinics is a major barrier to access that could be overcome by integrating pharmacists into the provision of PrEP services including prescribing and dispensing. Methods A number of reviews have shown promise in folding pharmacies into the expansion of PrEP services, but this review extends those by examining the implementation science evidence of pharmacist-led PrEP services in the US. We reviewed literature over the past five years of the implementation science of pharmacist PrEP services (2018–2023) and present seminal findings in this area. Results Only two studies are anchored within an implementation science framework despite all studies assessing common implementation science constructs. Overwhelming evidence supports feasibility and adoption of PrEP services in pharmacies yet gaps in workflow integration, scalability and sustainability exist. Conclusion Continuing to build the implementation science evidence of pharmacy-based PrEP services is critical to standardize our measures across varying contexts and inform policy efforts that support pharmacy-based PrEP services.
Funding Information
  • National Institute on Mental Health (1R34 MH119007, 1R34 MH119007, 1R34 MH119007, 1R34 MH119007)
  • National Institute of Allergy and Infectious Diseases (P30 AI050409, P30 AI050409, P30 AI050409, P30 AI050409)

This publication has 47 references indexed in Scilit: